These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5849597)

  • 21. ISOANTIGENIC PROPERTIES OF TUMORS TRANSGRESSING HISTOCOMPATIBILITY BARRIERS OF THE H-2 SYSTEM.
    MOELLER E
    J Natl Cancer Inst; 1964 Dec; 33():979-89. PubMed ID: 14241790
    [No Abstract]   [Full Text] [Related]  

  • 22. ATTEMPTS TO FIND CELL ASSOCIATED IMMUNE REACTION AGAINST AUTOCHTHONOUS TUMORS.
    YOSHIDA TO; SOUTHAM CM
    Jpn J Exp Med; 1963 Dec; 33():369-83. PubMed ID: 14148095
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
    Wagner JL; Haughton G
    J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191
    [No Abstract]   [Full Text] [Related]  

  • 24. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 25. Host responses to methylcholanthrene sarcoma and sheep red blood cell skeletal implants.
    Boak JL; Stolier AJ; Tebbutt S
    Clin Oncol; 1977 Dec; 3(4):345-51. PubMed ID: 598062
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor autoimmunity against methylcholanthrene-induced sarcomas of the rat.
    Takeda K; Aizawa M; Kikuchi Y; Yamawaki S; Nakamura K
    Gan; 1966 Jun; 57(3):221-40. PubMed ID: 5962636
    [No Abstract]   [Full Text] [Related]  

  • 27. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma].
    Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K
    Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
    Stjernswärd J
    J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
    [No Abstract]   [Full Text] [Related]  

  • 29. Demonstration of cellular antigens on sarcoma cells by an indirect 125-I-labeled antibody technique.
    Harder FH; McKhann CF
    J Natl Cancer Inst; 1968 Feb; 40(2):231-41. PubMed ID: 5638604
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in the opsonin and cellular influences on phagocytosis during the growth of transplantable tumors.
    Kampschmidt RF; Pulliam LA
    J Reticuloendothel Soc; 1972 Jan; 11(1):1-10. PubMed ID: 5060134
    [No Abstract]   [Full Text] [Related]  

  • 31. ANTIGENICITY OF A CRUDE LIPOPOLYSACCHARIDE FRACTION OF THE METHYLCHOLANTHRENE-INDUCED TUMOR, WITH SPECIAL REFERENCE TO ISOLOGOUS IMMUNITY IN INBRED RATS.
    MATSUMOTO T
    Gan; 1965 Feb; 56():1-11. PubMed ID: 14326031
    [No Abstract]   [Full Text] [Related]  

  • 32. [Proceedings: Immunity exhibited against the transplanted neoplasms by the homologous normal cells].
    Nakayama M; Hosokawa M; Imamura M; Oikawa K; Kobayashi H
    Hokkaido Igaku Zasshi; 1975 Jan; 50(1):82-3. PubMed ID: 1171067
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of anesthesia and amputation on tumor and general immunity of the mouse.
    Humphrey LJ; Frederickson EL; Amerson JR
    J Surg Res; 1970 Jun; 10(6):265-70. PubMed ID: 5462596
    [No Abstract]   [Full Text] [Related]  

  • 34. Sarcoma induction in mice by methylcholanthrene. The influence of thymus grafting and of castration.
    Marchant J
    Br J Cancer; 1969 Jun; 23(2):377-82. PubMed ID: 5788046
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of tumor growth with a new synthetic ribonucleic acid.
    Fisher JC; Cooperband SR; Mannick JA
    Surg Forum; 1970; 21():122-4. PubMed ID: 4328378
    [No Abstract]   [Full Text] [Related]  

  • 36. Implications of cancer immunity.
    Burnet FM
    Aust N Z J Med; 1973 Feb; 3(1):71-7. PubMed ID: 4573195
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
    Currie GA; Bagshawe KD
    Br J Cancer; 1969 Mar; 23(1):141-9. PubMed ID: 5768430
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppressed antibody response in mice treated with 3-methylcholanthrene at birth.
    Yasuhira K
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):33-7. PubMed ID: 5678192
    [No Abstract]   [Full Text] [Related]  

  • 39. [An attempt to detect humoral antineoplastic antibodies in mice immune to isogenic sarcomas induced by methylcholantrene].
    Lezhneva OM
    Biull Eksp Biol Med; 1965 Apr; 59(4):90-1. PubMed ID: 5864872
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of graft removal and immunosuppression on antibody response to murine histocompatibility antigens.
    Sparks FC; Canty TG; Ting CC; Hammond WG; Heberman RB
    Rev Surg; 1970; 27(5):374. PubMed ID: 4922239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.